Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
Quantum BioPharma Ltd., listed on NASDAQ as QNTM, announced its innovative drug candidate Lucid-MS, designed to directly target and repair the myelin sheath damaged in multiple sclerosis (MS). This novel approach differs fundamentally from existing therapies that only slow disease progression. Lucid-MS is preparing to enter phase 2 clinical trials,…